GSK Denied Quick Win In Flonase Antitrust Cases
GlaxoSmithKline PLC on Thursday lost a bid for summary judgment in three antitrust cases pending in Pennsylvania that allege the company delayed sales of a generic version of Flonase by filing...To view the full article, register now.
Already a subscriber? Click here to view full article